Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2017

Inadequate cancer screening: Lack of provider continuity is a
greater obstacle than medical mistrust
Lauren D. Arnold
Saint Louis University

Martha M.O. McGilvray
Washington University School of Medicine in St. Louis

J. Kyle Cooper
Harvard Medical School

Aimee S. James
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Arnold, Lauren D.; McGilvray, Martha M.O.; Cooper, J. Kyle; and James, Aimee S., ,"Inadequate cancer
screening: Lack of provider continuity is a greater obstacle than medical mistrust." Journal of Health Care
for the Poor and Underserved. 28,2. . (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5720

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Inadequate Cancer Screening: Lack of Provider Continuity is a Greater Obstacle
than Medical Mistrust
Lauren D. Arnold, Martha M. O. McGilvray, J. Kyle Cooper, Aimee S. James
Journal of Health Care for the Poor and Underserved, Volume 28, Number
1, February 2017, pp. 362-377 (Article)
Published by Johns Hopkins University Press
DOI: https://doi.org/10.1353/hpu.2017.0028

For additional information about this article
https://muse.jhu.edu/article/648766

Access provided by Washington University @ St. Louis (10 Apr 2017 23:42 GMT)

ORIGINAL PAPER

Inadequate Cancer Screening: Lack of
Provider Continuity is a Greater Obstacle
than Medical Mistrust
Lauren D. Arnold, PhD, MPH (co-First Author, first listed)
Martha M. O. McGilvray, MSt, BA (co-First Author, second listed)
J. Kyle Cooper, BA
Aimee S. James, PhD, MPH
Abstract: Background. Racial minorities and low-income individuals are generally less likely
to have adequate cancer screening than Whites or higher-income individuals. Purpose. To
examine the roles of medical mistrust and lack of provider continuity in cancer screening
in a low-income minority population. Methods. A total of 144 urban federally qualified
health center patients completed a cross-sectional survey that included the Group Based
Medical Mistrust Scale and questions on provider continuity and cancer-screening-history.
Results. Breast cancer screening was associated with continuity of care but not mistrust
(respectively p = .002, p > .05); colon cancer screening was not significantly associated with
either factor (p > .05). Conclusions. Findings suggest that among low-income minority
adults continuity of care is more strongly associated with screening than medical mistrust.
Shifting focus from medical mistrust—a patient-level issue—to establishing health care
homes—a system-level issue—may be a more effective strategy for reducing racial and
socioeconomic disparities in cancer screening.
Key words: Mistrust, continuity of care, cancer screening, racial minorities, low income,
breast cancer, colon cancer

C

ancer mortality is disproportionately prevalent among racial minorities and lowincome individuals.1,2 Compared with their White counterparts, Blacks experience
higher mortality for all cancers combined, and for breast and colon cancer individually.3
Low-income individuals also experience higher mortality for breast cancer and colorectal cancer (CRC).4,5 One major factor fueling these disparities is late-stage diagnosis,
which leads to worse initial prognosis.1
Cancer screening reduces CRC and breast cancer mortality.6–11 Despite this, many
individuals in the U.S. do not receive screening at recommended intervals, especially
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racial minorities and low-income individuals.2,12–14 For example, national survey data
found that only 44.2% and 56.3% of individuals with an income less than 139% of
the federal poverty threshold had recent CRC screening and recent mammography,
respectively, compared with 65.5% and 81.8% of individuals with an income greater
than 400% of the poverty threshold.12
There are a plethora of commonly cited potential factors associated with suboptimal
cancer screening.12,13,15–20 Two important but less well characterized proposed factors
are medical mistrust (i.e., mistrust of the health care system or providers) and lack of
provider continuity (i.e., having a consistent provider or health care home).21–26 La Veist
et al. showed that mistrust toward health care organizations leads to failure to take
medical advice and to keep follow-up appointments,27 while Brookhart et al. showed
that provider continuity is positively associated with medical adherence.28 Given that
medical mistrust and lack of provider continuity are thought to be more common
among racial minorities and low-income populations,25,29–32 their potential role in the
observed cancer mortality disparities among these groups should be explored.
Both medical mistrust and lack of provider continuity are linked to complicated
structures of racial and socioeconomic discrimination, and the resulting lack of social
resources and support. Thus, neither is easily ameliorated. When prioritizing one factor as a first target for intervention, an important preliminary question is: is one of
these two factors more significantly linked to adequacy of cancer screening, and thus
disparities in mortality? Survey data from a cross-sectional study in a low-income
minority population were used to explore this question.

Methods
Overview and study design. Survey data were collected from patients at a network
of urban federally qualified health centers (FQHCs) as part of a longitudinal, observational study on CRC screening behaviors. This cross-sectional analysis of baseline
data was performed to investigate potential associations between cancer screening and
both medical mistrust (a scale variable) and provider continuity (a binary categorical
variable). Study procedures were approved by the Washington University in Saint Louis
School of Medicine (Saint Louis, MO) Institutional Review Board.
Participants. Participants were recruited from the patient populations of three
FQHCs in St. Louis, Missouri. Patients were eligible to participate if they spoke English
and were 40 years of age or older. Participants received a $15 gift card upon survey
completion.
Measures. Participants completed a baseline survey, either by interviewer-administration
(69%) or on their own (31%). Outcomes of interest were ever having been screened
for CRC or breast cancer as assessed by self-report. Screening measures queried were
fecal occult blood testing (FOBT), flexible sigmoidoscopy, and colonoscopy for CRC
and mammography for breast cancer. National Cancer Institute (NCI) CRC screening
measures33 were used in their original form to measure CRC screening and in modified
form to measure breast cancer screening. The two primary independent variables were
medical mistrust and provider continuity. Mistrust was evaluated using the GroupBased Medical Mistrust Scale (α = 0.877). This scale was designed to assess mistrust
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within the context of health care and racial discrimination and has been validated in
Black men and women.34,35 Individuals were categorized as having provider continuity if they answered “yes” to the question “Is there a particular doctor’s office, clinic,
or health center that you regularly go to when you are sick?” Additional variables
of interest included age, gender, race, education level, income level, and insurance
status.
Analysis. Total medical mistrust scores were calculated by summing scores for the
12 individual items generating a scale from 0 to 60, with a higher score indicating a
greater level of mistrust. Medical mistrust scale scores were then assessed across groups
categorized by age, race, gender, income, and insurance status using t-tests, and groups
categorized by education level using ANOVA. Continuity of care was assessed across
those same groups using chi-square tests. The association between medical mistrust
and continuity of care was evaluated using a t-test.
American Cancer Society screening guidelines were used to identify the appropriate subpopulations for analysis of specific cancer screening modalities: mammography analysis was restricted to women ≥40 years and CRC screening analysis to men
and women ≥50 years. Based on their yes/no answers to screening history questions,
participants were scored as either had ever been screened or had never been screened
for mammography and for any CRC screening (FOBT, sigmoidoscopy, colonoscopy).
Mistrust and provider continuity were assessed across ever/never screened groups by
t-tests and chi-square tests, respectively. All analyses were conducted using IBM SPSS
Statistics v.22.36

Results
Demographic characteristics. The sample population consisted of 144 individuals
(Table 1) with a mean age of 51 years (SD = 7) who were predominately Black and
male (87.5% and 61.8%, respectively). Over one third (36.1%) of participants had not
completed high school or attained a GED , and about one quarter (24.3%) reported
education beyond high school. Participants faced considerable socioeconomic challenges.
The majority (70.8%) reported a monthly income below $800 (less than $9,600 annually). A similarly large proportion (75.0%) reported having ever been homeless (i.e.,
ever spent longer than 24 hours on the streets or in a shelter). Uninsured participants
comprised 52.1% of the sample population, with an additional 10.4% reporting that
despite having insurance at the time of the survey, they had experienced a coverage
gap in the previous 12-month period. Despite the high percentage of uninsured participants, 84.7% reported they had a regular health care source. This likely reflects the
health center based recruitment strategy and the eligibility requirement for participants
to be a patient at these centers.
Medical mistrust demographic characteristics. A total of 123 individuals had
complete responses to the 12-item Group-Based Medical Mistrust Scale. Significant
differences in mistrust were seen across groups by race and insurance status (Table 2).
Blacks had higher mistrust scores than individuals of other races (mean(SD): 31.0(9.1)
vs. 26.2(8.4); p = .04). Individuals with health insurance had higher levels of mistrust
than uninsured individuals (mean(SD): 32.0(9.8) vs. 28.6(8.2); p = .04). There were
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Table 1.
PARTICIPANT DEMOGRAPHICSa

Variable
Age (years)
Race
Black
Other
Gender
Male
Female
Highest Level of Education
< high school (HS) graduation or GED
HS graduation or GED
> HS graduation or GED
Employment Status
Unemployed (non-disabled)
Monthly Income
< $800
≥ $800
Insurance Status
Uninsured
Insured

Mean (±SD) or
frequency (proportion)
51 (±7)
126 (87.5%)
18 (12.5%)
89 (61.8%)
55 (38.2%)
52 (36.1%)
55 (38.2%)
35 (24.3%)
71 (49.3%)
102 (70.8%)
33 (22.9%)
75 (52.1%)
64 (44.4%)

a

N = 144. Percentages within individual demographic factors may not sum to 100% due to participantomitted answers.

no significant differences in mistrust by gender, highest level of education, or monthly
income. A selection of the most commonly endorsed mistrust statements are shown
in Table 3.
Provider-continuity demographic characteristics. A total of 143 individuals
responded to the provider-continuity question (Table 4). A significant difference in provider continuity was only seen across groups by insurance status. A greater percentage
of individuals with health insurance had a regular provider than uninsured individuals
(93.8% vs. 79.7%; χ2 = 5.68 [df = 1], p = .02). There were no significant differences in
provider continuity by race, gender, highest level of education, or monthly income.
Medical mistrust vs. provider continuity. Medical mistrust and provider continuity
were not significantly associated (n = 122; p = .85).
Cancer screening by medical mistrust vs. provider continuity. Among women
40 years or older who responded to the relevant survey questions, there was a significant difference in history of mammography across groups by provider continuity
(n = 55, χ2 = 9.75 [df = 1], p = .002; Table 5) but not by medical mistrust (n = 45, p =
.81). Specifically, women who reported continuity of medical care were more likely to

Table 2.
MEDICAL MISTRUST BY DEMOGRAPHIC CHARACTERISTICSa

Demographic characteristic
Race
Black
Other
Gender
Male
Female
Highest Level of Education
< HS grad or GED
HS grad or GED
> HS grad or GED
Monthly Income
< $800
≥ $800
Insurance Status
Uninsured
Insured

Sample Size

Medical Mistrust
Score (mean ± SD)

105
18

31.0 ± 9.1
26.2 ± 8.4

.04

78
45

30.1 ± 9.3
30.7 ± 8.9

.73

44
47
30

31.8 ± 8.0
30.2 ± 9.5
27.9 ± 9.4

.19

89
27

30.0 ± 9.1
30.5 ± 9.5

.79

69
50

28.6 ± 8.2
32.0 ± 9.8

.04

p-value

a

Mistrust measured by the Group Based Medical Mistrust Scale with scores ranging from 0 to 60; a
higher score indicates a greater level of mistrust.

Table 3.
REPONSES TO SELECTED ITEMS FROM THE GROUP BASED
MEDICAL MISTRUST SCALE
Mistrust Item
Doctors and health care workers sometimes hide information
from patients who belong to my ethnic group.
Doctors and health care workers treat people of my ethnic
group as “guinea pigs”.
I have personally been treated poorly or unfairly by doctors or
health care workers because of my ethnicity.
People of my ethnic group cannot trust doctors and health care
workers.

Population % (n)a
36% (49)
25% (33)
22% (30)
17% (23)

a
Sample sizes for each question reflect the total number of participants who answered that question
(in descending order: n = 135, 134, 136, 136). Participants who answered either “Strongly Agree” or
“Agree” were included in the percentages reported above.

Table 4.
CONTINUITY OF MEDICAL CARE BY DEMOGRAPHIC
CHARACTERISTICS

Demographic characteristic

Sample Size

Has a Regular
Provider
(proportion)

125
18

84.0%
94.4%

.24

88
55

84.1%
87.3%

.60

51
55
35

80.4%
81.8%
97.1%

.07

102
33

83.3%
93.9%

.13

74
64

79.7%
93.8%

.02

Race
Black
Other
Gender
Male
Female
Highest Level of Education
< HS grad or GED
HS grad or GED
> HS grad or GED
Monthly Income
< $800
≥ $800
Insurance Status
Uninsured
Insured

p-value

Table 5.
RATES OF CANCER SCREENING BY LEVEL OF MEDICAL
MISTRUST AND CONTINUITY OF CARE
Medical Mistrust

Screening
modality
Mammogram
Ever
Never
CRC Screening
Ever
Never

Sample
size

Continuity of Medical Care

Mistrust score
(mean ± SD) p-value

Sample
size

Has a Regular
Provider
(proportion)

p-value

37
8

30.9 ± 9.5
30.0 ± 6.0

.81

46
9

93.5%
55.6%

.002

37
30

31.9 ± 10.1
30.9 ± 8.3

.68

42
37

92.9%
78.4%

.06

CRC = Colorectal Cancer
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have ever received breast cancer screening than individuals without continuity of care
(93.5% vs. 55.6%).
Among individuals aged 50 or older, those who had provider continuity had higher
rates of CRC screening than those without continuity—92.9% of individuals with continuity had ever received CRC screening vs. 78.4% without—but the difference was
not statistically significant (n = 79, p = .06). In contrast, individuals who had received
CRC screening had a higher mean mistrust score than those who had not received
screening (mean ± SD: ever CRC screening 31.9 ± 10.1 vs. never CRC screening 30.9
± 8.3), but again this result was not significant (n = 67, p = .68).
Additional analyses. Race, education and income levels, and insurance status were
not significantly associated with either mammography or CRC screening, and gender
was also not significantly associated with CRC screening (all p values > .05).

Discussion
Key findings. The study population faced pronounced disparities—most participants
were below the national poverty line, had at some point been homeless, and lacked postsecondary education. Within this population, we examined the associations of medical
mistrust and provider continuity with cancer screening, and found that continuity
was more strongly associated with having ever had mammography than was mistrust.
This cross-sectional survey study found that continuity of medical care, but not
medical mistrust, was significantly associated with adequate breast cancer screening.
That having a regular provider is important for maintaining a good standard of care is
consistent with previous studies37–39 and is conceptually logical. Patients and physicians
can only develop a therapeutic relationship when they have repeated clinical encounters.
Such a relationship enables the physician to gain a more complete picture of the patient’s
medical history and screening/preventative needs. Regular use of the same clinical office
or team also creates a secure and familiar space in which the patient and provider can
discuss the patient’s health and health care plan in a non-emergent setting.37–39
Given that other studies have linked medical mistrust with inadequate care,27,40–42 it
may seem surprising that in this study population, high levels of medical mistrust were
not associated with inadequate breast cancer screening. However, the interplay of mistrust, screening/preventive medicine, and patient outcomes is likely quite complicated
and not easily captured using a 12-item tool. The Group Based Medical Mistrust Scale
asks general questions about health care providers and the medical field, with most
questions oriented toward how a group of people are treated, rather than the individual
answering the questions (e.g., “people of my ethnic group”). These questions do not
assess an individual patient’s level of trust in a specific provider or institution, which
may 1) vary significantly from their level of trust in the medical field as a whole, and
2) be much more functionally relevant for adherence to prevention guidelines.
Indeed, it would be an oversimplification to claim that provider continuity and
mistrust—and their impact on quality/adequacy of care—are independent from each
other. It is difficult for a patient to build trust with a provider they meet only once or
a clinic they use only once, and presumably more feasible to build trust with a familiar
provider one expects to see again. This idea is supported by a number of studies that
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have found continuity of care is positively correlated with medical trust across sample
populations and more specifically within minority subgroups.37,43 Furthermore, in a
sample of 1,031 men Carpenter et al. found that having a regular provider was associated both with greater trust and with screening for prostate cancer.25
Many studies have investigated the complex relationships between race, mistrust,
provider continuity, and health care utilization,23,26,27,29,30,34,41,44–47 but as a field, public
health is still only beginning to understand these complex interconnections. There are
a variety of mistrust measures that have been used to investigate these questions: the
Medical Mistrust Index,29 the Primary Care Assessment Survey,48 the Stanford Trust
in Physician Scale,49 and the Group-Based Medical Mistrust Scale (used in the current
study). Many of these measures ask about patients as a group or as members of specific
racial or ethnic groups, providers as a whole, or the health care system as a singular
entity. Some ask about a patient’s experience with the health care system as a whole, or
even a specific relationship between one patient and one doctor, but leave out queries
concerning race and racial discrimination. To our knowledge, no studies have simultaneously asked about an individual patient’s experience with an individual provider
with specific reference to the role the patient’s race plays in that interaction. Perhaps
this is a gap in our literature that it would be important and enlightening to fill in.
However, investigating this gap could be analytically quite complex. Should the
specific provider be designated as the provider/practice the individual visits most often,
or whatever practice is chosen as the point of study recruitment/participation? How
can individuals whose regular provider is a physician be compared with those whose
regular provider is a nurse practitioner or physician’s assistant, or some combination
thereof? How can such a measure be standardized across both populations with and
without a regular provider? Regarding the latter question, some studies have opted to
only include those potential participants who do have a regular care home,48,49 but in
doing so have resigned themselves to not addressing an important side of the mistrust
issue. Measuring medical mistrust by treating the entire medical field as a single entity
has practical benefits in that it allows for comparison across individuals with disparate
access to and interaction with medical providers. Unfortunately, the same simplicity
that makes such a measure methodologically attractive may miss an important element
of mistrust.
Advantages and limitations. While this study comes to a potentially important
conclusion that continuity of care may be a larger driver of screening behavior than
medical mistrust among low-income primary care patients, it is important to keep in
mind its limitations. First, because this is a cross-sectional study, it is not possible to
assess causal relationships between cancer screening behaviors and both mistrust and
provider continuity. Secondly, this study relied on participant self-report for screening
history and provider continuity. Although this may not always be accurate, several studies have supported the use and validity of self-report for assessing cancer screening.33,50
Third, knowing that participants usually see the same provider at the FQHCs in this
study, continuity of care was operationalized as having a usual clinic or office where
care is obtained. While it can be argued that continuity and usual source of care are
different concepts, there is evidence that having a regular provider at a usual source
is more effective than having a usual source of care alone.51,52 Thus, due to the way
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continuity was defined in this study, the magnitude of association between continuity
and cancer screening may be underestimated.
As previously noted, a more comprehensive medical mistrust measure that asks
participants to evaluate their own interactions with a specific provider/practice and
with the more general health care system as a whole, while also assessing the role
race plays in those interactions might better characterize this complex matter. The
Group Based Medical Mistrust Scale was developed and tested in African American
and Latina women for the purpose of assessing medical mistrust as it relates to racial/
ethnic health disparities.34 While race and ethnicity are different concepts, the Scale
uses “ethnicity” as an encompassing term for both race and ethnicity, and it has been
validated among Blacks, demonstrating applicability to race. Because a predominantly
African American sample, such as that in this study, is likely to over-represent those
who have high mistrust, future studies might utilize quota sampling to recruit other
racial/ethnic groups and thereby minimize homogeneity of the sample.
Additionally, the small sample size (n = 144) limited the study’s ability to detect significant differences, draw more definitive conclusions, and adjust analyses by multiple
demographic variables. This limitation was more pronounced when isolating subgroups
that were eligible for mammography or CRC screening and had also completed the
mistrust or provider-continuity measures. For example, almost two thirds of the sample
population was male and thus not eligible for standard breast cancer screening. Despite
the small sample size, this study was able to gain insight into a unique population
underrepresented in published research. The demographic make-up, in particular the
relatively homogeneous nature of the sample population (i.e., mostly Black, low-income)
may have also contributed to the lack of expected correlation observed between demographic characteristics and cancer screening. This homogeneity also limited the study’s
ability to make intergroup comparisons and to expand the study’s conclusions more
generally outside of this specific population. In future studies, quota sampling could be
used to ensure adequate representation of different subpopulations (e.g. gender, race)
to allow for inter-group comparisons.
However, the demographic characteristics of the study population also add richness
to our findings. While it is often the case in survey studies that the majority of participants are female,53–55 in this study the majority were male. This allows for insights
to be drawn for a population often under represented both in research and in health
care utilization more generally.56,57 The same can be said of the nearly homogeneous
racial makeup, lack of higher education, and pronounced poverty of the sample population—more than 70% of participants had an annual income of less than $10,000,
placing them well below the national poverty threshold. While many studies have
characterized populations at high risk for inadequate medical/preventative care, this
study characterized a population at the very limit of high risk and low resources. Sampling such an exceptionally high-risk and low-resource population allows this study to
draw conclusions and propose future interventions targeted at those patients who are
most in need. Such specific prioritization is especially important within the context of
limited health care resources and health care disparities.
As the target population in this study was underserved individuals, a convenience
sampling strategy was used with the sampling frame of FQHC patients. This popula-
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tion may include individuals who use a specific center for routine care as well as those
who are transient and do not routinely visit a specific center. It is likely that due to
this sampling strategy, individuals with a usual source of care are over-represented in
the sample. To address this limitation, future studies may include a community-based
sampling component.
Implications for future interventions. Medical mistrust and continuity of care are
both complicated systems-level issues. Medical mistrust is staggeringly complex and
is inseparable from a long-standing history of institutionalized discrimination that
reaches far beyond the borders of the health care field. As such, it has no clear or simple
solution. While continuity of care and the dearth of health care homes is a similarly
complex issue, because it is directly within the purview of the health care system, it
seems more feasibly solvable by those within that system.
For some providers, it may be all too easy to dismiss individual patients’ nonadherence to medical guidelines out of hand, or indeed patients themselves as mistrusting, uninformed, or non-compliant. Prioritizing providing consistent longitudinal
care can re-direct this counter-productive focus on the perceived limitations of an
individual patient instead into a productive improvement of the shortcomings of the
health care system.39
This study in no way aims to minimize the importance of medical mistrust, and
interventions to address this remain important. Indeed, this study’s findings on mistrust
are sobering (Table 3). Over a third of participants considered health care providers to
be (intentionally or unintentionally) racially-biased. A quarter of patients agreed that
“doctors and health care workers treat people of my ethnic group as ‘guinea pigs’.” These
simple statistics indicate potential challenges for members of racial/ethnic minority
groups and low-income individuals interacting with the health care system and should
inform future effort to ameliorate mistrust and its effects.
Medical mistrust is likely a mechanism of negative patient outcomes, but it could
also be considered an outcome in and of itself. It would not be unreasonable to conclude that patients who at the completion of treatment or medical encounter do not
trust their provider or feel that their care was negatively affected by their race have not
received the standard of care. It may be more ethically cautious to conceptualize medical mistrust as an outcome rather than a patient attribute or mechanism as that will,
at least to some extent, ensure that not all responsibility will be placed on the patient.
As for functional application, interventions that build better continuity of care at the
systems-level, especially for high-risk populations, may improve both cancer-screening
rates and trust on the interpersonal level.
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